S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
Are blue chip stocks a good investment?
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Power Play: GE's game-changing technology for EVs and grids
Home sales hit a 13-year low... what now?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Stock market today: World shares mixed after Wall St ends its best month of '23 with big gains
Salesforce.com completes a reversal: new all-time high in sight
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
A 15% gain in store for Five Below after rosy holiday outlook
Salesforce, Big Lots rise; Pure Storage, Cracker Barrel fall, Thursday, 11/30/2023
S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
Are blue chip stocks a good investment?
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Power Play: GE's game-changing technology for EVs and grids
Home sales hit a 13-year low... what now?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Stock market today: World shares mixed after Wall St ends its best month of '23 with big gains
Salesforce.com completes a reversal: new all-time high in sight
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
A 15% gain in store for Five Below after rosy holiday outlook
Salesforce, Big Lots rise; Pure Storage, Cracker Barrel fall, Thursday, 11/30/2023
S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
Are blue chip stocks a good investment?
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Power Play: GE's game-changing technology for EVs and grids
Home sales hit a 13-year low... what now?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Stock market today: World shares mixed after Wall St ends its best month of '23 with big gains
Salesforce.com completes a reversal: new all-time high in sight
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
A 15% gain in store for Five Below after rosy holiday outlook
Salesforce, Big Lots rise; Pure Storage, Cracker Barrel fall, Thursday, 11/30/2023
S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
Are blue chip stocks a good investment?
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Power Play: GE's game-changing technology for EVs and grids
Home sales hit a 13-year low... what now?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Stock market today: World shares mixed after Wall St ends its best month of '23 with big gains
Salesforce.com completes a reversal: new all-time high in sight
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
A 15% gain in store for Five Below after rosy holiday outlook
Salesforce, Big Lots rise; Pure Storage, Cracker Barrel fall, Thursday, 11/30/2023

Immix Biopharma (IMMX) Insider Trading & Ownership

$5.11
+0.03 (+0.59%)
(As of 11/30/2023 ET)
Compare
Today's Range
$4.91
▼
$5.19
50-Day Range
$2.82
▼
$5.28
52-Week Range
$1.01
▼
$5.47
Volume
108,471 shs
Average Volume
220,881 shs
Market Capitalization
$101.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.00
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media

Immix Biopharma (NASDAQ:IMMX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
55.90%
Number Of
Insiders Buying
(Last 12 Months)
4
Amount Of
Insider Buying
(Last 12 Months)
$140,190.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get IMMX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Immix Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

IMMX Insider Buying and Selling by Quarter


Immix Biopharma Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/14/2023Carey NgDirectorBuy10,000$2.58$25,800.00  
9/12/2023Helen C AdamsDirectorBuy13,000$2.96$38,480.00  
9/7/2023Melissa Jane BuchanDirectorBuy20,000$2.46$49,200.00  
9/5/2023Magda MarquetDirectorBuy10,000$2.47$24,700.00  
8/31/2023Magda MarquetDirectorBuy1,000$2.01$2,010.00  
(Data available from 1/1/2013 forward)












IMMX Insider Trading Activity - Frequently Asked Questions

Who is on Immix Biopharma's Insider Roster?

The list of insiders at Immix Biopharma includes Carey Ng, Helen C Adams, Ilya M Rachman, Magda Marquet, Melissa Jane Buchan, and Sean Senn. Learn more on insiders at IMMX.

What percentage of Immix Biopharma stock is owned by insiders?

55.90% of Immix Biopharma stock is owned by insiders. Learn more on IMMX's insider holdings.

Which Immix Biopharma insiders have been buying company stock?

The following insiders have purchased IMMX shares in the last 24 months: Carey Ng ($25,800.00), Helen C Adams ($38,480.00), Ilya M Rachman ($5,200.00), Magda Marquet ($26,710.00), and Melissa Jane Buchan ($49,200.00).

How much insider buying is happening at Immix Biopharma?

Insiders have purchased a total of 59,200 IMMX shares in the last 24 months for a total of $145,390.00 bought.

Which Immix Biopharma insiders have been selling company stock?

The following insider sold IMMX shares in the last 24 months: Sean Senn ($550.00).

How much insider selling is happening at Immix Biopharma?

Insiders have sold a total of 200 Immix Biopharma shares in the last 24 months for a total of $550.00 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:IMMX) was last updated on 12/1/2023 by MarketBeat.com Staff

My Account -